The American Journal of Medicine
Volume 76, Issue 6 , Pages 1006-1012 , June 1984

Interstitial nephritis, proteinuria, and renal failure caused by nonsteroidal anti-inflammatory drugs: Immunologic characterization of the inflammatory infiltrate

  • Walter L. Bender, M.D.

      Affiliations

    • Corresponding Author InformationCurrent address and address for reprint requests: Department of Medicine, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, Maryland 21205.
    • From the Departments of Medicine and Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • ,
  • Andrew Whelton, M.D.

      Affiliations

    • From the Departments of Medicine and Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • ,
  • William E. Beschorner, M.D.

      Affiliations

    • From the Departments of Medicine and Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • ,
  • Mamdouh O. Darwish, M.D.

      Affiliations

    • From the Departments of Medicine and Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • ,
  • Mary Hall-Craggs, M.D.

      Affiliations

    • From the Departments of Medicine and Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
    • Current address: Department of Pathology, University of Maryland, 22 South Greene Street, Baltimore, Maryland 21201.
  • ,
  • Kim Solez, M.D.

      Affiliations

    • From the Departments of Medicine and Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
    • Dr. Solez is a recipient of United States Public Health Service Research Career Development Award AM-00835.

,Accepted 2 December 1983.

References 

  1. Blackshear JL, Davidman M, Stillman M. Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs. Arch Intern Med. 1983;143:1130–1134
  2. Henrich WL. Nephrotoxicity of nonsteroidal anti-inflammatory agents. Am J Kidney Dis. 1983;2:478–484
  3. Bernheim JL, Korzets C. Indomethacin-induced renal failure. Ann Intern Med. 1979;91:792
  4. Kimberly RP, Brandstetter RD. Exacerbation of phenylbutazone-related renal failure by indomethacin. Arch Intern Med. 1978;138:1711–1712
  5. Tan SY, Shapiro R, Kish MA. Reversible acute renal failure induced by indomethacin. JAMA. 1979;241:2732–2733
  6. Findling JW, Beckstrom D, Rawsthorne L, Kozin F, Itskovita H. Indomethacin induced hyperkalemia in three patients with gouty arthritis. JAMA. 1980;244:1127–1128
  7. Walshe JJ, Venuto RC. Acute oliguric renal failure induced by indomethacin: possible mechanism. Ann Intern Med. 1979;91:47–49
  8. Gary NE, Dodelson R, Eisinger RP. Indomethacin associated acute renal failure. Am J Med. 1980;65:135–136
  9. O'Meara NE, Eknoyan G. Acute renal failure associated with indomethacin administration. South Med J. 1980;73:587–589
  10. Katz SM, Capaldo R, Everts EA, DiGregorio JG. Tolmetin association with reversible renal failure and acute interstitial nephritis. JAMA. 1981;246:243–245
  11. Fellner SK, Affarah HB, Wolfe C. Acute renal failure after zomepirac. Arch Intern Med. 1981;141:1846
  12. Wendland ML, Wagoner RD, Holley KE. Renal failure associated with fenoprofen. In: 10th ed. Mayo Clin Proc. 55:1980;p. 103–107
  13. Finkelstein A, Fraley DS, Stachura I, Feldman HA, Gandhi DR, Bourke E. Fenoprofen nephropathy: lipoid nephrosis in interstitial nephritis: a possible T lymphocyte disorder. Am J Med. 1982;72:81–87
  14. Robertson CE, Van Someren G, Ford NJ, Dlugolecka M, Prescott LF. Mefenamic acid nephropathy. Lancet. 1980;II:232–233
  15. Fong HJ, Cohen AH. Ibuprofen-induced acute renal failure with acute tubular necrosis. Am J Nephrol. 1982;2:28–31
  16. Curt GA, Kaldany A, Whitley LG, et al. Reversible rapidly progressive renal failure with nephrotic syndrome due to fenoprofen calcium. Ann Intern Med. 1980;92:70–73
  17. Lofgren RP, Nelson AE, Ehlers SN. Fenoprofen induced acute interstitial nephritis presenting with nephrotic syndrome. Minn Med. 1981;64:287–290
  18. Lomvardias S, Pinn DW, Wadhwa ML, Koshy KM, Haller M. Nephrotic syndrome associated with sulindac (abstr). N Engl J Med. 1981;304:424
  19. Brezin JH, Katz SM, Schwartz AB, Chinltz JL. Reversible renal failure and nephrotic syndrome associated with nonsteroidal anti-inflammatory drugs. N Engl J Med. 1979;301:1271–1273
  20. Miller FC, Schorr WJ, Lacher JW. Zomepirac-induced renal failure. Arch Intern Med. 1983;143:1171–1173
  21. Husby G, Tung KSK, Williams RC. Characterization of renal tissue lymphocytes in patients with interstitial nephritis. Am J Med. 1981;70:31–38
  22. Platt JL, LeBien TW, Michael AF. Interstitial mononuclear cell populations in renal graft rejection: identification by monoclonal antibodies in tissue sections. J Exp Med. 1982;155:17–30
  23. Beschorner WE, Hess AD. Mouse monoclonal antibody specific for human cytotoxic T lymphocytes and precursors (abst). Lab Invest. 1983;48:9A
  24. Tan SY, Shapiro RS, Franco R, et al. Indomethacin-induced prostaglandin inhibition with hyperkalemia: a reversible cause of hyporeminemic hypoaldosteronism (abstr). Clin Res. 1977;25:598A
  25. Dunn MJ, Zambraski EJ. Renal effects of drugs that inhibit prostaglandin synthesis. Kidney Int. 1980;18:609–622
  26. Stachura I, Jayakumar S, Bourke E. T and B lymphocyte subsets in fenoprofen nephropathy. Am J Med. 1983;75:9–16
  27. Steward RB, Hale WE, Marks RG. Effects of nonsteroidal anti-inflammatory drugs in renal function in the elderly. South Med J. 1982;75:824–826
  28. Favre L, Glasson PH, Riondel A, Vallotton MB. Interaction of diuretics and non-steroidal anti-inflammatory drugs in man. Clin Sci. 1983;64:407–415
  29. Bunning RD, Barth WF. Sulindac: a potentially renal-sparing nonsteroidal anti-inflammatory drug. JAMA. 1982;248:2864–2867
  30. Whelton A, Bender WL, Vaghaiwalla F, Hall-Craggs M, Solez K. Sulindac and renal impairment (letter). JAMA. 1983;249:2892
  31. Lifschitz MD. Renal effects of nonsteroidal anti-inflammatory agents. J Lab Clin Med. 1983;102:313–323
  32. Frais MA, Burgess ED, Mitchell LB. Piroxicam-induced renal failure and hyperkalemia. Ann Intern Med. 1983;99:129–130
  33. Coles LS, Fries JF, Kraines RG, Roth SH. From experiment to experience: side effects of nonsteroidal anti-inflammatory drugs. Am J Med. 1983;74:820–828
  34. Zollinger HU, Mihatsch MJ. Renal pathology in biopsy. In: New York: Springer-Verlag; 1978;p. 129
  35. Sraer J-D, Sraer J, Ardaillou R, Richet G. The glomerulus: site of synthesis and target for hormones and chemical mediators. In: 10th ed.  Hamburger J,  Crosnier J,  Grunfeld J-P,  Maxwell MH editor. Advances in nephrology. vol 10:Chicago: Year Book Medical; 1981;p. 293–314

 This study was supported in part by United States Public Health Service Grant AM-26809 and by a grant from Dista Products Company. Data were entered on the CLINFO computer system, supported by United States Public Health Service Grant RR35-20.

PII: 0002-9343(84)90849-0

The American Journal of Medicine
Volume 76, Issue 6 , Pages 1006-1012 , June 1984